Molecular diagnostic developers face both internal and external pressures to reduce costs and improve assay performance. For example, the reverse transcription step in an RT-PCR assay drastically increases complexity encountered in molecular diagnostics. Using fast, inhibitor tolerant, and lyo-compatible reverse transcriptases can help reduce the burden on developers by enabling short overall turnaround times, streamlining or eliminating purification, and simplifying shipping and storage. Selecting the appropriate components to address the challenges in your assay can be a daunting task. At Roche CustomBiotech, we are here to assist you in finding solutions and overcoming these obstacles. Explore our wide range of reagents designed for the unique requirements of centralized and point-of-care diagnostic assay development.
